EYPT Stock Analysis: Buy, Sell, or Hold?
EYPT - EyePoint Pharmaceuticals, Inc. Common Stock
$13.39
0.37 (2.80%)
▲
5d:
+2.49%
30d:
-25.64%
90d:
-26.74%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 06, 2026
Smart Money Accumulation
EYPT is down 7.6% this week, but smart money is accumulating calls. Top strike: $10 2026-05-15 with 15 OI. Call ratio: 65% View Scanner →
Strength: 5.3/10
Get Alerted When EYPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: EYPT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: EYPT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: EYPT is currently trading at $13.38, which is considered oversold relative to its 30-day fair value range of $12.92 to $17.00.
Technical Outlook: Technically, EYPT is showing sideways momentum. Immediate support is located at $11.82, while resistance sits at $13.86.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.42 (+187.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EYPT is showing sideways momentum. Immediate support is located at $11.82, while resistance sits at $13.86.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.42 (+187.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$12.92 -
$17.00
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 187.4% below Wall St target ($37.42)
Fair Price Analysis
30-Day Fair Range
$12.92 -
$17.00
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$11.82
Resistance Level
$13.86
Current Trend
Sideways
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.74
Wall Street Target
$37.42
(+187.4%)
Revenue Growth (YoY)
-94.7%
Share & Embed Analysis
Last updated: April 02, 2026 2:32 PM ET
Data refreshes hourly during market hours. Next update: 3:32 PM
Data refreshes hourly during market hours. Next update: 3:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EYPT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Jay S Duker
BUY
1500 shares
2026-03-16
Ramiro Ribeiro
SELL
42544 shares
2026-01-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 62 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 60 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 51 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$50 | 54 HOLD |
